23 The SURMOUNT-1 trial revealed a mean percent change in BW over placebo of 15%, 19.5% and 20.9% in those receiving tirzepatide at doses of 5, 10, and 15 mg, respectively
Burgdorf S , Kautz A , Bhnert V , Knolle PA , Kurts CJs
Customized Stacking We design specific combinations for home use
Exogenous AntioxidantsDouble-Edged Swords in Cellular Redox State: Health Beneficial Effects at Physiologic Doses versus Deleterious Effects at High Doses
Practical, evidence-based menopause support still includes: Lab testing for hormones, thyroid, and nutrients Targeted supplementation (vitamin D, magnesium, B vitamins, omega-3s) Dietary strategies that reduce inflammation and balance blood sugar Lifestyle interventions like strength training, sleep hygiene, and stress reduction Hormone therapy when appropriate, monitored carefully The Bottom Line BPC-157 shows promise in areas relevant to menopausegut healing, joint repair, and possibly mood support